The biosynthetic potential of myxobacteria and their impact in drug discovery
- PMID:19333867
The biosynthetic potential of myxobacteria and their impact in drug discovery
Abstract
Myxobacteria produce an immense variety of natural products with useful biological activities. This review highlights recent advances to evaluate and further explore their biosynthetic potential for drug discovery, with particular focus on polyketide synthase and non-ribosomal peptide synthetase-derived secondary metabolites.
Similar articles
- Myxobacterial natural product assembly lines: fascinating examples of curious biochemistry.Wenzel SC, Müller R.Wenzel SC, et al.Nat Prod Rep. 2007 Dec;24(6):1211-24. doi: 10.1039/b706416k. Epub 2007 Jun 11.Nat Prod Rep. 2007.PMID:18033576Review.
- Genomic mining--a concept for the discovery of new bioactive natural products.Gross H.Gross H.Curr Opin Drug Discov Devel. 2009 Mar;12(2):207-19.Curr Opin Drug Discov Devel. 2009.PMID:19333866Review.
- Non-modular polyketide synthases in myxobacteria.Li Y, Müller R.Li Y, et al.Phytochemistry. 2009 Oct-Nov;70(15-16):1850-7. doi: 10.1016/j.phytochem.2009.05.003. Epub 2009 Jul 6.Phytochemistry. 2009.PMID:19586645Review.
- [Application of molecular biology for the discovery of biosynthetic genes of polyketide and peptide antibiotics produced by actinomycetes].Kotowska M.Kotowska M.Postepy Biochem. 2005;51(3):345-52.Postepy Biochem. 2005.PMID:16381179Review.Polish.
- [The PKS/NRPS hetero-gene cluster of epothilones].Li ZF, Nguimbi E, Li YZ, Liu WF.Li ZF, et al.Sheng Wu Gong Cheng Xue Bao. 2003 Sep;19(5):511-5.Sheng Wu Gong Cheng Xue Bao. 2003.PMID:15969075Review.Chinese.
Cited by
- Comprehensive set of integrative plasmid vectors for copper-inducible gene expression in Myxococcus xanthus.Gómez-Santos N, Treuner-Lange A, Moraleda-Muñoz A, García-Bravo E, García-Hernández R, Martínez-Cayuela M, Pérez J, Søgaard-Andersen L, Muñoz-Dorado J.Gómez-Santos N, et al.Appl Environ Microbiol. 2012 Apr;78(8):2515-21. doi: 10.1128/AEM.07502-11. Epub 2012 Jan 27.Appl Environ Microbiol. 2012.PMID:22287008Free PMC article.
- New strategies for drug discovery: activation of silent or weakly expressed microbial gene clusters.Ochi K, Hosaka T.Ochi K, et al.Appl Microbiol Biotechnol. 2013 Jan;97(1):87-98. doi: 10.1007/s00253-012-4551-9. Epub 2012 Nov 11.Appl Microbiol Biotechnol. 2013.PMID:23143535Free PMC article.Review.
- Marine myxobacteria as a source of antibiotics--comparison of physiology, polyketide-type genes and antibiotic production of three new isolates of Enhygromyxa salina.Schäberle TF, Goralski E, Neu E, Erol O, Hölzl G, Dörmann P, Bierbaum G, König GM.Schäberle TF, et al.Mar Drugs. 2010 Sep 3;8(9):2466-79. doi: 10.3390/md8092466.Mar Drugs. 2010.PMID:20948900Free PMC article.
- Activation and products of the cryptic secondary metabolite biosynthetic gene clusters by rifampin resistance (rpoB) mutations in actinomycetes.Tanaka Y, Kasahara K, Hirose Y, Murakami K, Kugimiya R, Ochi K.Tanaka Y, et al.J Bacteriol. 2013 Jul;195(13):2959-70. doi: 10.1128/JB.00147-13. Epub 2013 Apr 19.J Bacteriol. 2013.PMID:23603745Free PMC article.
- Chimaeric load among sympatric social bacteria increases with genotype richness.Mendes-Soares H, Chen IC, Fitzpatrick K, Velicer GJ.Mendes-Soares H, et al.Proc Biol Sci. 2014 Jul 22;281(1787):20140285. doi: 10.1098/rspb.2014.0285.Proc Biol Sci. 2014.PMID:24870038Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Other Literature Sources